Results 111 to 120 of about 64,645 (182)

[Infectious Disease Prevention Group: Update on vaccines, 2022]. [PDF]

Aten Primaria, 2022
Martín Martín S, Morató Agustí ML, Javierre Miranda AP, Sánchez Hernández C, Schwarz Chavarri G, Aldaz Herce P, García Iglesias C, Gómez Marco JJ, Gutiérrez Pérez MI, Grupo de Prevención de Enfermedades Infecciosas del PAPPS.   +9 more
europepmc   +1 more source

[Retrospective observational study of the persistence of SARS-CoV-2 infection in patients previously treated with rituximab]. [PDF]

Rev Esp Quimioter, 2022
Gómez Lluch MT, Proy Vega B, Cabero Becerra M, Rodríguez A, Escalera Zalvide A, Sánchez SA.   +5 more
europepmc   +1 more source

[Experience with medical treatment using sirolimus for cardiac rhabdomyomas in children. A case series]. [PDF]

Arch Cardiol Mex
Stelmaszewski EV, Olivetti ME, Diez-Mori F, Salgado G.   +3 more
europepmc   +1 more source

[Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis]. [PDF]

Rev Neurol, 2022
García-Estévez DA, Pérez-Lorenzo G, Fernández-Pérez MJ, Cid-Rodríguez C, Ozaita-Arteche G.   +4 more
europepmc   +1 more source

[Nirsevimab immunization effectiveness against respiratory syncytial virus hospitalization in newborns: two season of use in Navarre, Spain]. [PDF]

An Sist Sanit Navar
Vera-Punzano N, Navascués A, Armendáriz L, Viguria N, Herranz-Aguirre M, García Cenoz M, Trobajo-Sanmartín C, Echeverria A, Martínez-Baz I, Ezpeleta C, Ezpeleta G, Castilla J.   +11 more
europepmc   +1 more source

Consensus document on the use of sacubitril/valsartan in patients with heart failure: Consejo Interamericano de Falla Cardiaca e Hipertensión Pulmonar (CIFACAH) of the Inter-American Society of Cardiology (IASC). [PDF]

Arch Cardiol Mex, 2023
Speranza M, Saldarriaga C, Ramos CE, Quesada D, Rossel V, Ventura-Umanzor JR, Pow-Chon F, Alarco W, Figueroa Y, Magaña A, Gómez-Mesa JE, Rodríguez-García D.   +11 more
europepmc   +1 more source

[Effects of the COVID-19 pandemic on the immunization program for children under 5 years of age in EcuadorEfeitos da pandemia de COVID-19 no programa de imunização de menores de cinco anos no Equador]. [PDF]

Rev Panam Salud Publica
Osorio López EA, Urquieta-Salomón JE, Alfaro Quevedo Pinos M, Espinoza Suárez JB, Becerril-Montekio V, Espinosa-Henao OE, Alcalde-Rabanal JE.   +6 more
europepmc   +1 more source

[Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study]. [PDF]

Rev Esp Anestesiol Reanim, 2023
Ferrandis R, Escontrela B, Ferrando C, Hernández M, Herrera J, Hidalgo F, Librero J, Llau JV, Martínez A, Pajares A, Tapia B, Arruti E, Bassas E, Blasi A, Calvo A, en representación del COVID-19 Spanish ICU Network Group.   +15 more
europepmc   +1 more source

[Gemcitabine-induced digital necrosis in a patient with cervical squamous cell carcinoma: case report and literature review]. [PDF]

Rev Colomb Obstet Ginecol
Guarín-Rivera S, Pineda-Arango H, Balaguera-Becerra C, Carreño-Jaimes M, Utria-Munive J.   +4 more
europepmc   +1 more source

[Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management]. [PDF]

Rev Esp Cardiol, 2023
Barreiro-Pérez M, Pastor Pueyo P, Raposeiras-Roubín S, Montero Corominas D, Uribarri A, Eiros Bachiller R, Rozado Castaño J, García-Cuenllas Álvarez L, Serratosa Fernández L, Domínguez F, Pascual Figal D.   +10 more
europepmc   +1 more source